Abstract 13816: Dantrolene Enhances Binding of Calmodulin to RyR2 in CPVT Which Mutation Located at Central Domain but Does Not Enhance That in CPVT With Mutation at CaM-like Domain

IntroductionCatecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by heterozygous mutation in RyR2 gene. Most mutations are known to be located at N-terminal domain, central domain or C-terminal channel pore region. Meanwhile, amino acid residues from 4026 to 4172 of RyR2 have EF ha...

Full description

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) Vol. 132; no. Suppl_3 Suppl 3; p. A13816
Main Authors: Nishimura, Shigehiko, Yamamoto, Takeshi, Fukui, Go, Maeda, Takako, Hino, Akihiro, Suetomi, Takeshi, Ono, Makoto, Mochizuki, Mamoru, Oda, Tetsuro, Okuda, Shinichi, Kobayashi, Shigeki, Yano, Masafumi
Format: Journal Article
Language:English
Published: by the American College of Cardiology Foundation and the American Heart Association, Inc 10-11-2015
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract IntroductionCatecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by heterozygous mutation in RyR2 gene. Most mutations are known to be located at N-terminal domain, central domain or C-terminal channel pore region. Meanwhile, amino acid residues from 4026 to 4172 of RyR2 have EF hand motifs and are called calmodulin (CaM)-like domain (CaMLD). Some of the human CPVT mutations were reported in this CaMLD. In this study we investigated the molecular mechanism of arrhythmogenesis of CPVT with mutation at CaMLD comparing R2474S and N4103K KI mice.Methods and ResultsVT and/or Vf were frequently observed after caffeine plus epinephrine infusion in KI mice (R2474S100%, N4103K43%), but not in WT mice. CaM binding affinity to RyR2 was assessed by incorporation of exogenous CaM labeled with HiLyte Fluor® in isolated saponin-permeabilized cardiomyocytes. The CaM binding affinity was decreased in both R2474S-KI (Kd400 nM) and N4103K-KI cells (Kd165 nM) compared with WT cells (Kd90 nM) in the presence of cAMP. Addition of 1 μM dantrolene (DAN), the zipper of N-terminal and central domain of RyR2, increased the affinity of CaM to RyR2 in R2474S-KI cells, but did not increase that in N4103K-KI cells. Frequency of the Ca sparks (SpF) was measured in isolated saponin-permeabilized cardiomyocytes. SpF was much higher in KI cells than in WT cells (R2474S-KI17.2±6.7, N4103K-KI21.5±6.3, WT10.6±4.1). Addition of 1 μM DAN to R2474S-KI cells significantly decreases SpF (10.4±5.5), however, DAN did not decrease SpF in N4103K-KI (21.8±6.9). Spontaneous Ca transient (SCaT) was measured during sequential pacing from 1 to 5 Hz in isolated intact cardiomyocytes. The SCaT was rarely observed in WT cells even with 10 nM isoproterenol, whereas that was observed in 37 % of R2474S-KI and in 33 % of N4103K-KI cells. Addition of DAN to KI cells, decrease frequency of SCaT in R2474S-KI (13 %), however, did not decrease in N4103-KI cells (30 %).ConclusionsIn CPVT with central domain mutation, domain zipper is effective to inhibit arrhythmias. In CaMLD mutation, structural abnormality might be in the downstream of the N-terminal and central domain switch, so that the DAN is not effective. CaMLD might be a novel therapeutic target of lethal arrhythmias.
AbstractList IntroductionCatecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by heterozygous mutation in RyR2 gene. Most mutations are known to be located at N-terminal domain, central domain or C-terminal channel pore region. Meanwhile, amino acid residues from 4026 to 4172 of RyR2 have EF hand motifs and are called calmodulin (CaM)-like domain (CaMLD). Some of the human CPVT mutations were reported in this CaMLD. In this study we investigated the molecular mechanism of arrhythmogenesis of CPVT with mutation at CaMLD comparing R2474S and N4103K KI mice.Methods and ResultsVT and/or Vf were frequently observed after caffeine plus epinephrine infusion in KI mice (R2474S100%, N4103K43%), but not in WT mice. CaM binding affinity to RyR2 was assessed by incorporation of exogenous CaM labeled with HiLyte Fluor® in isolated saponin-permeabilized cardiomyocytes. The CaM binding affinity was decreased in both R2474S-KI (Kd400 nM) and N4103K-KI cells (Kd165 nM) compared with WT cells (Kd90 nM) in the presence of cAMP. Addition of 1 μM dantrolene (DAN), the zipper of N-terminal and central domain of RyR2, increased the affinity of CaM to RyR2 in R2474S-KI cells, but did not increase that in N4103K-KI cells. Frequency of the Ca sparks (SpF) was measured in isolated saponin-permeabilized cardiomyocytes. SpF was much higher in KI cells than in WT cells (R2474S-KI17.2±6.7, N4103K-KI21.5±6.3, WT10.6±4.1). Addition of 1 μM DAN to R2474S-KI cells significantly decreases SpF (10.4±5.5), however, DAN did not decrease SpF in N4103K-KI (21.8±6.9). Spontaneous Ca transient (SCaT) was measured during sequential pacing from 1 to 5 Hz in isolated intact cardiomyocytes. The SCaT was rarely observed in WT cells even with 10 nM isoproterenol, whereas that was observed in 37 % of R2474S-KI and in 33 % of N4103K-KI cells. Addition of DAN to KI cells, decrease frequency of SCaT in R2474S-KI (13 %), however, did not decrease in N4103-KI cells (30 %).ConclusionsIn CPVT with central domain mutation, domain zipper is effective to inhibit arrhythmias. In CaMLD mutation, structural abnormality might be in the downstream of the N-terminal and central domain switch, so that the DAN is not effective. CaMLD might be a novel therapeutic target of lethal arrhythmias.
Abstract only Introduction: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by heterozygous mutation in RyR2 gene. Most mutations are known to be located at N-terminal domain, central domain or C-terminal channel pore region. Meanwhile, amino acid residues from 4026 to 4172 of RyR2 have EF hand motifs and are called calmodulin (CaM)-like domain (CaMLD). Some of the human CPVT mutations were reported in this CaMLD. In this study we investigated the molecular mechanism of arrhythmogenesis of CPVT with mutation at CaMLD comparing R2474S and N4103K KI mice. Methods and Results: VT and/or Vf were frequently observed after caffeine plus epinephrine infusion in KI mice (R2474S: 100%, N4103K: 43%), but not in WT mice. CaM binding affinity to RyR2 was assessed by incorporation of exogenous CaM labeled with HiLyte Fluor® in isolated saponin-permeabilized cardiomyocytes. The CaM binding affinity was decreased in both R2474S-KI (Kd: 400 nM) and N4103K-KI cells (Kd: 165 nM) compared with WT cells (Kd: 90 nM) in the presence of cAMP. Addition of 1 μM dantrolene (DAN), the zipper of N-terminal and central domain of RyR2, increased the affinity of CaM to RyR2 in R2474S-KI cells, but did not increase that in N4103K-KI cells. Frequency of the Ca 2+ sparks (SpF) was measured in isolated saponin-permeabilized cardiomyocytes. SpF was much higher in KI cells than in WT cells (R2474S-KI: 17.2±6.7, N4103K-KI: 21.5±6.3, WT: 10.6±4.1). Addition of 1 μM DAN to R2474S-KI cells significantly decreases SpF (10.4±5.5), however, DAN did not decrease SpF in N4103K-KI (21.8±6.9). Spontaneous Ca 2+ transient (SCaT) was measured during sequential pacing from 1 to 5 Hz in isolated intact cardiomyocytes. The SCaT was rarely observed in WT cells even with 10 nM isoproterenol, whereas that was observed in 37 % of R2474S-KI and in 33 % of N4103K-KI cells. Addition of DAN to KI cells, decrease frequency of SCaT in R2474S-KI (13 %), however, did not decrease in N4103-KI cells (30 %). Conclusions: In CPVT with central domain mutation, domain zipper is effective to inhibit arrhythmias. In CaMLD mutation, structural abnormality might be in the downstream of the N-terminal and central domain switch, so that the DAN is not effective. CaMLD might be a novel therapeutic target of lethal arrhythmias.
Author Yamamoto, Takeshi
Ono, Makoto
Oda, Tetsuro
Fukui, Go
Maeda, Takako
Okuda, Shinichi
Hino, Akihiro
Kobayashi, Shigeki
Nishimura, Shigehiko
Suetomi, Takeshi
Mochizuki, Mamoru
Yano, Masafumi
AuthorAffiliation 1Dept of Medicine and Clinical Science, Yamaguchi Universiy Graduate Sch of Medicine, Ube, Japan 2Div of Cardiology, Yamaguchi Universiy Graduate Sch of Medicine, Ube, Japan
AuthorAffiliation_xml – name: 1Dept of Medicine and Clinical Science, Yamaguchi Universiy Graduate Sch of Medicine, Ube, Japan 2Div of Cardiology, Yamaguchi Universiy Graduate Sch of Medicine, Ube, Japan
Author_xml – sequence: 1
  givenname: Shigehiko
  surname: Nishimura
  fullname: Nishimura, Shigehiko
  organization: 1Dept of Medicine and Clinical Science, Yamaguchi Universiy Graduate Sch of Medicine, Ube, Japan 2Div of Cardiology, Yamaguchi Universiy Graduate Sch of Medicine, Ube, Japan
– sequence: 2
  givenname: Takeshi
  surname: Yamamoto
  fullname: Yamamoto, Takeshi
– sequence: 3
  givenname: Go
  surname: Fukui
  fullname: Fukui, Go
– sequence: 4
  givenname: Takako
  surname: Maeda
  fullname: Maeda, Takako
– sequence: 5
  givenname: Akihiro
  surname: Hino
  fullname: Hino, Akihiro
– sequence: 6
  givenname: Takeshi
  surname: Suetomi
  fullname: Suetomi, Takeshi
– sequence: 7
  givenname: Makoto
  surname: Ono
  fullname: Ono, Makoto
– sequence: 8
  givenname: Mamoru
  surname: Mochizuki
  fullname: Mochizuki, Mamoru
– sequence: 9
  givenname: Tetsuro
  surname: Oda
  fullname: Oda, Tetsuro
– sequence: 10
  givenname: Shinichi
  surname: Okuda
  fullname: Okuda, Shinichi
– sequence: 11
  givenname: Shigeki
  surname: Kobayashi
  fullname: Kobayashi, Shigeki
– sequence: 12
  givenname: Masafumi
  surname: Yano
  fullname: Yano, Masafumi
BookMark eNpNkN1O3DAQRi1EpS60r1D5BbL4J4k3vYNAS6WFVnTVXlpjxyEuXntlO0I8GO9XL2wrruYbab4z0jlBxz54g9AnSpaUtvRM26iXlLNlmnc7J3nJK9oeoQVtWF3VDe-O0YIQ0lWCM_YenaT0p6wtF80CPZ-rlCPojF9an_El-ByDM97gKz-B1ybhC-sH6-9xGHEPbhuG2VmPc8B3T3cMl9j_-LXBvyerJ3wzZ8g2eLwOGrIZMGTcm8IEhy_DFsq1mnOJhXsb8r8neDOVw_8om9-Q9gS4qZx9MAfEB_RuBJfMx8M8RT-_XG3662r9_eu3_nxd6Y41ldJM1LpuBtK20CkQQqxGJYzSahCMkUGreqxXdTuScTCUmo4BVyOsBiW4ovwUta9UHUNK0YxyF-0W4pOkRO7Vy716WdTLg3r5IrEU69fiY3DZxPTg5kcT5WTA5UkW94QTKipGaEMpJbwiZTT8L9emjSw
ContentType Journal Article
Copyright 2015 by the American College of Cardiology Foundation and the American Heart Association, Inc.
Copyright_xml – notice: 2015 by the American College of Cardiology Foundation and the American Heart Association, Inc.
DBID AAYXX
CITATION
DOI 10.1161/circ.132.suppl_3.13816
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
CrossRef
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1524-4539
EndPage A13816
ExternalDocumentID 10_1161_circ_132_suppl_3_13816
00003017-201511103-01115
GroupedDBID -
.XZ
.Z2
01R
0R
1AW
1J1
29B
2WC
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
71W
77Y
7O
7O~
8RP
AAAXR
AAMOA
AAMTA
AAPBV
AARTV
AAWTL
AAXQO
ABBUW
ABFLS
ABOCM
ABPMR
ABPTK
ABUFD
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFS
ACRKK
ACWDW
ACWRI
ACXNZ
ADBBV
ADCYY
AE3
AENEX
AFCHL
AFUWQ
AHMBA
AHULI
AHVBC
AIJEX
AJIOK
ALMA_UNASSIGNED_HOLDINGS
AMJPA
ASCII
ASPBG
AVWKF
AWKKM
AZFZN
BAWUL
BOYCO
BQLVK
BYPQX
C45
CS3
DIK
DU5
E3Z
EBS
EJD
EX3
F2K
F2L
F2M
F2N
F5P
GX1
H0
H0~
H1
H13
HZ
IKYAY
IN
IN~
JF9
JG8
JK3
K8S
KD2
KMI
KQ8
L-C
L7B
N9A
N~7
N~B
O0-
O9-
OAG
OAH
OBH
OCB
ODA
OGEVE
OHASI
OK1
OL1
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWW
OWY
OXXIT
P2P
PQEST
PQQKQ
RAH
RHF
RIG
RLZ
RSW
S4R
S4S
UPT
V2I
W2D
WH7
WOQ
WOW
X3V
X3W
XZ
YZZ
Z2
ZA5
ZY1
~H1
---
.-D
.3C
0R~
0ZK
18M
2FS
354
6PF
AAAAV
AAGIX
AAHPQ
AAIQE
AAJCS
AAQKA
AASCR
AASOK
AASXQ
AAUEB
AAYXX
ABASU
ABDIG
ABJNI
ABQRW
ABVCZ
ACCJW
ACGFO
ACILI
ACLDA
ACOAL
ACXJB
ADGGA
ADHPY
AE6
AEBDS
AEETU
AFDTB
AFEXH
AFSOK
AGINI
AHOMT
AHQNM
AHRYX
AINUH
AJNWD
AJZMW
AKULP
ALMTX
AMKUR
AMNEI
AOHHW
AYCSE
CITATION
DIWNM
EEVPB
ERAAH
FCALG
GNXGY
GQDEL
HLJTE
HZ~
IKREB
IPNFZ
K-A
K-F
ODMTH
OHH
OHYEH
OJAPA
OLB
OWBYB
OWU
OWV
OWX
OWZ
T8P
TEORI
TR2
TSPGW
VVN
W3M
W8F
XXN
XYM
YFH
YOC
YSK
YYM
ZFV
ZZMQN
ID FETCH-LOGICAL-c925-bc274c45d066a9ba7778fb7ebcbd7220dcb4f4846f0fde11e92a3bfa8db73b13
ISSN 0009-7322
IngestDate Thu Nov 21 23:07:48 EST 2024
Thu Aug 13 19:45:49 EDT 2020
IsPeerReviewed true
IsScholarly true
Issue Suppl_3 Suppl 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c925-bc274c45d066a9ba7778fb7ebcbd7220dcb4f4846f0fde11e92a3bfa8db73b13
ParticipantIDs crossref_primary_10_1161_circ_132_suppl_3_13816
wolterskluwer_health_00003017-201511103-01115
ProviderPackageCode OVOZU
L-C
C45
7O~
AARTV
ABPMR
OLH
ASCII
BYPQX
OLG
AAMOA
ODA
ABZAD
ABBUW
JK3
H0~
1J1
OLV
OLU
JG8
OLW
OLZ
OLY
F2K
F2M
F2L
F2N
OHASI
AHVBC
KMI
OGEVE
K8S
OVLEI
AJIOK
OPUJH
V2I
.XZ
S4R
S4S
4Q1
OAG
4Q2
OVDNE
4Q3
AMJPA
OAH
OVD
71W
AHULI
ACEWG
.Z2
N~7
IKYAY
OVIDH
AWKKM
40H
N~B
OBH
X3V
X3W
ACDDN
ACWRI
BOYCO
AIJEX
AAXQO
~H1
AAMTA
AAAXR
OWW
OCB
OWY
01R
ACXNZ
OL1
AFCHL
ABXVJ
IN~
KD2
OXXIT
77Y
ACWDW
JF9
PublicationCentury 2000
PublicationDate 2015-November-10
2015-11-10
PublicationDateYYYYMMDD 2015-11-10
PublicationDate_xml – month: 11
  year: 2015
  text: 2015-November-10
  day: 10
PublicationDecade 2010
PublicationTitle Circulation (New York, N.Y.)
PublicationYear 2015
Publisher by the American College of Cardiology Foundation and the American Heart Association, Inc
Publisher_xml – name: by the American College of Cardiology Foundation and the American Heart Association, Inc
SSID ssj0006375
Score 2.2161772
Snippet IntroductionCatecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by heterozygous mutation in RyR2 gene. Most mutations are known to be...
Abstract only Introduction: Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by heterozygous mutation in RyR2 gene. Most mutations are...
SourceID crossref
wolterskluwer
SourceType Aggregation Database
Publisher
StartPage A13816
Title Abstract 13816: Dantrolene Enhances Binding of Calmodulin to RyR2 in CPVT Which Mutation Located at Central Domain but Does Not Enhance That in CPVT With Mutation at CaM-like Domain
URI http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00003017-201511103-01115
Volume 132
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9swEBf9gDEYY2s31n2hh7EXoza27NjZW5ZlS6EJowljb0aW5dpksUdjM_qH7f_bnSx_hHawPuzFEUI5Ef_upztd7iRC3kWBGLqeTJh0PY-BheYs8NSQjeKR63GHS66wOHm29Bffg09Td7q335RWdX3_FWnoA6yxcvYeaLdCoQPagDk8AXV4_hPu4wiDF7K0bPyzDjf8ACxmo8OiZk3zFFHeWh-zupqlrs7aFLFOSAc_9PLm0tGVgF-_wVY_zWRqzSuTkXhRYPpUjPWPJigM_vdGwOioKqEJchdF2UxirVJRdqIw3ttKQglizn5ka2VE9J3kSXYtza1id10W1AteLDCCtqn0XUnWMs2uVJqti3YlExsBmqiDwSuxVjC2VddqXek8hi_t6LlQsTBDhRFiwiG2x3RKXqvA6LN3JTl5P_wy0Qm--mCr7sqqNk-1_cYM9K7sk-NWUir6pczndT31qTKGw3FB1euDmVrL0oVuKyztgX1FyC39afGe1Rhrjej5IF3HbQs3RAsnAYhTEA8WVgs97UnYOT18UG96fYbvCuyazp6z8VSGQweWZrAMh-PJ-cV5670Mue81tw_ibzRV9TDt2d2T7jh0j34VmOSxXesaj56ntnpCHpstFh3X3HhK9lR-RI7HuSiLzQ19T3XSs0boiDyYm9ySY_K7YQ7VE36gHW9owxtqeEOLhHa8oWVBkTcUmqjsVPOGNtpODW-oKKnhDa2VngJvKPKGAm-aSSjyphMFvOkkoQTDGyPiGVl-nq4mM2YuNWFy5Hgsko7vwroYg6svRpHwfT9IIl9FMop9xxnEMnITFzYFySCJlW2rkSN4lIggjnwe2fw5OciLXL0gNBABePcB574CD1Mmo4BLJw6SwB1wMZD2CTlrcAl_1ifXhHrHP7RDRDIEJEODZKhf7AlhO_CFdSl2-DcdennP8a_Iw46xr8lBeV2pN2R_G1dvjRb-AQy48zI
link.rule.ids 315,782,786,27933,27934,64549,64569,65344,65364
linkProvider Ovid
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1Lb9NAEF5BKgES4tGCKM89IN_cxl7bu0bKwXUcAiRWVVsUTtY-bMVqY1eNA-oP4_8xu3GqcODAhZNH8mqs9X6ax-43Owi9F4wHni8rW3q-b4OHJjbzy8AOVej5xCWSlLo4eZrR9BsbJ_qanC1XVRefra6O9MOYaS3odjg6L8xHnzMrTc6zUWPFWTz6bp1GHxOzTa1JEtZ41P6oOitKDf2KaPML3g0CCsdQhhxdir4X-CTwBmgvmozzk1uTHRDqb1uuUYB4X0oM0dCxrK_lEaRsYMsgLCwIyEw3R9_xYg9_tvpke3VhiO077mny-D9N7Al61MevONoA7im6Uzb76CBqIHdf3mALG0ap2arfR_fm_cH9AfoVCb2nIjtsJvYBA9o0RR4sLU6ahYbeCp_UpsQGtxWO-eWyVZolj7sWn92cuRjE-PRrjs8XtVzg-XrDIcCzVnO6FOYd7neq8bhdchgt1h2IoDdtu-1HcL6Agbeq6m5Hk9bA5_ZlfVH2Kp6hbJLk8dTuO0bYMnR9W0jIsQF0CuIoHgpOKWWVoKWQQlHXHSopvMqDiKsaVqp0nDJ0OREVZ0pQIhzyHA2atilfIMw4g9CJEUJLcN-yChmRrmIVpMOED6VziI63619cba4FKUw6FTiFRkwBiCl6xBTmxx4i-w-YFJs61-JvS_ryH8e_Q_en-XxWzD6lX16hB_qtbdiKr9Ggu16Xb9DdlVq_7ZH_G-68DEE
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1bb5RAFJ5omzQmpmqrsfU2D4Y32oXhMpjwQIG1apdsCrH6ROYCWdIuNF1Wsz_M_-eZWbZZH3zwxSdOwuTAwMe5zXcYhN5zyjzHFbUpHNc1wUMTk7qVZwYycFxiE0Eq1Zx8nvvZN5qk6jc5mxV81Xy2uD1RB22mlaC2w1F5YRF-zo04j8PvRpZe5WFmTKOPqS5TK5KEMU3G4cpIwu5H3RtRpklYRBlh8HEQVliaOGSphvRduD0PPoHdaJwUZ_eG2yO-u9l4zQegDw3FEBOdiuZOnEDiBhYNgsOSgEzVFulbvuzxz06tby-uNb19y0mNn_zX6T1F-0Msi6M1-J6hB1V7gA6jFvL4-QobWLNLddn-AO1NhkX8Q_Qr4qq-Inqsp_cBA_IUXR6sLk7bmYLhAp81ut0GdzWO2c28k4oxj_sOX64ubQxiPP1a4KtZI2Z4slzzCfBFp_hdErMeD1VrnHRzBqP5sgcR9GZdv7kILmYw8F5V029pUhrYxLxprqtBxXOUj9MiPjeH3SNMEdiuyQXk2wBACTEVCzjzfZ_W3K-44NK37ZEU3KkdiL7qUS0ry6oCmxFeMyq5T7hFXqCdtmurlwhTRiGMooT4FbhyUQeUCFvSGlJjwkbCOkKnGxSUt-tfhJQ6tfKsUuGmBNyUA25K_WCPkPkHWMp1z2v5t1d6_I_j36E9QEt58Sn78go9UidNTVx8jXb6u2X1Bj1cyOXbAf6_AdFWDyM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Abstract+13816%3A+Dantrolene+Enhances+Binding+of+Calmodulin+to+RyR2+in+CPVT+Which+Mutation+Located+at+Central+Domain+but+Does+Not+Enhance+That+in+CPVT+With+Mutation+at+CaM-like+Domain&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Nishimura%2C+Shigehiko&rft.au=Yamamoto%2C+Takeshi&rft.au=Fukui%2C+Go&rft.au=Maeda%2C+Takako&rft.date=2015-11-10&rft.pub=by+the+American+College+of+Cardiology+Foundation+and+the+American+Heart+Association%2C+Inc&rft.issn=0009-7322&rft.eissn=1524-4539&rft.volume=132&rft.issue=Suppl_3+Suppl+3&rft.spage=A13816&rft.epage=A13816&rft_id=info:doi/10.1161%2Fcirc.132.suppl_3.13816&rft.externalDocID=00003017-201511103-01115
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7322&client=summon